Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 3
1990 5
1991 5
1992 8
1993 6
1994 3
1995 6
1996 5
1997 4
1998 4
1999 3
2000 6
2001 8
2002 7
2003 8
2004 6
2005 11
2006 7
2007 4
2008 7
2009 5
2010 6
2011 7
2012 11
2013 10
2014 13
2015 10
2016 5
2017 14
2018 16
2019 10
2020 15
2021 10
2022 8
2023 9
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Results by year

Filters applied: . Clear all
Page 1
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.
Roddie C, Dias J, O'Reilly MA, Abbasian M, Cadinanos-Garai A, Vispute K, Bosshard-Carter L, Mitsikakou M, Mehra V, Roddy H, Hartley JA, Spanswick V, Lowe H, Popova B, Clifton-Hadley L, Wheeler G, Olejnik J, Bloor A, Irvine D, Wood L, Marzolini MAV, Domning S, Farzaneh F, Lowdell MW, Linch DC, Pule MA, Peggs KS. Roddie C, et al. Among authors: o reilly ma. J Clin Oncol. 2021 Oct 20;39(30):3352-3363. doi: 10.1200/JCO.21.00917. Epub 2021 Aug 31. J Clin Oncol. 2021. PMID: 34464155 Free PMC article. Clinical Trial.
Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma.
Roddie C, Lekakis LJ, Marzolini MAV, Ramakrishnan A, Zhang Y, Hu Y, Peddareddigari VGR, Khokhar N, Chen R, Basilico S, Raymond M, Vargas FA, Duffy K, Brugger W, O'Reilly MA, Wood L, Linch DC, Peggs KS, Bachier C, Budde EL, Lee Batlevi C, Bartlett N, Irvine D, Tholouli E, Osborne W, Ardeshna KM, Pule MA. Roddie C, et al. Among authors: o reilly ma. Blood. 2023 May 18;141(20):2470-2482. doi: 10.1182/blood.2022018598. Blood. 2023. PMID: 36821767 Free PMC article.
Ultrasound-responsive droplets for therapy: A review.
Lea-Banks H, O'Reilly MA, Hynynen K. Lea-Banks H, et al. Among authors: o reilly ma. J Control Release. 2019 Jan 10;293:144-154. doi: 10.1016/j.jconrel.2018.11.028. Epub 2018 Nov 29. J Control Release. 2019. PMID: 30503398 Free PMC article. Review.
Kyphomelic dysplasia.
O'Reilly MA, Hall CM. O'Reilly MA, et al. J Med Genet. 1994 May;31(5):423. doi: 10.1136/jmg.31.5.423-a. J Med Genet. 1994. PMID: 8064826 Free PMC article. No abstract available.
Hajdu-Cheney syndrome.
O'Reilly MA, Shaw DG. O'Reilly MA, et al. Ann Rheum Dis. 1994 Apr;53(4):276-9. doi: 10.1136/ard.53.4.276. Ann Rheum Dis. 1994. PMID: 8203959 Free PMC article. No abstract available.
Out of Tune: Fibroblasts Turn Fibrotic When They Lack a FENDRR.
Woeller CF, O'Reilly MA. Woeller CF, et al. Among authors: o reilly ma. Am J Respir Cell Mol Biol. 2020 Apr;62(4):403-404. doi: 10.1165/rcmb.2019-0379ED. Am J Respir Cell Mol Biol. 2020. PMID: 31805248 Free PMC article. No abstract available.
Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery.
Kooiman K, Roovers S, Langeveld SAG, Kleven RT, Dewitte H, O'Reilly MA, Escoffre JM, Bouakaz A, Verweij MD, Hynynen K, Lentacker I, Stride E, Holland CK. Kooiman K, et al. Among authors: o reilly ma. Ultrasound Med Biol. 2020 Jun;46(6):1296-1325. doi: 10.1016/j.ultrasmedbio.2020.01.002. Epub 2020 Mar 10. Ultrasound Med Biol. 2020. PMID: 32165014 Free PMC article. Review.
247 results